592
Views
0
CrossRef citations to date
0
Altmetric
Influenza

Epidemic patterns of the different influenza virus types and subtypes/lineages for 10 years in Chongqing, China, 2010–2019

, , , , , , , & show all
Article: 2363076 | Received 25 Feb 2024, Accepted 30 May 2024, Published online: 07 Jun 2024

References

  • Sarker A, Gu Z, Mao L, Ge Y, Hou D, Fang J, Wei Z, Wang Z. Influenza-existing drugs and treatment prospects. Eur J Med Chem. 2022 Mar 15;232:114189. doi:10.1016/j.ejmech.2022.114189.
  • Rybakowski J. Infections and mental diseases: from tuberculosis to COVID-19. Psychiatr Pol. 2022 Oct 31;56(5):931–7. English, Polish. 10.12740/PP/152125.
  • Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S, Cohen C, Gran JM, Schanzer D, Cowling BJ, et al. Global seasonal influenza-associated mortality collaborator network. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2018 Mar 31;391(10127):1285–300. doi:10.1016/S0140-6736(17)33293-2.
  • Paget J, Staadegaard L, Wang X, Li Y, van Pomeren T, van Summeren J, Dückers M, Chaves SS, Johnson EK, Mahé C, et al. Global and national influenza-associated hospitalisation rates: estimates for 40 countries and administrative regions. J Glob Health. 2023 Jan 27;13:04003. doi:10.7189/jogh.13.04003.
  • Qi L, Li Q, Ding XB, Gao Y, Ling H, Liu T, Xiong Y, Su K, Tang WG, Feng LZ, et al. Mortality burden from seasonal influenza in Chongqing, China, 2012–2018. Hum Vaccin Immunother. 2020 Jul 2;16(7):1668–74. doi:10.1080/21645515.2019.1693721.
  • Li L, Liu Y, Wu P, Peng Z, Wang X, Chen T, Wong JYT, Yang J, Bond HS, Wang L, et al. Influenza-associated excess respiratory mortality in China, 2010–15: a population-based study. Lancet Public Health. 2019 Sep;4(9):473–81. doi:10.1016/S2468-2667(19)30163-X.
  • Chongqing Bureau of Statistics. Statistical bulletin on national economic and social development of Chongqing municipality. 2023. https://tjj.cq.gov.cn/zwgk_233/fdzdgknr/tjxx/sjzl_55471/tjgb_55472/202403/t20240326_13084652.html.
  • Qi L, Xiong Y, Xiao B, Tang W, Ling H, Long J, Xiao D, Zhao H, Ye S, Chen S, et al. Epidemiological and virological characteristics of influenza in Chongqing, China, 2011–2015. PLOS ONE. 2016 Dec 9;11(12):e0167866. doi:10.1371/journal.pone.0167866.
  • China National Influenza Center. National influenza surveillance technical guidelines. (2017 Edition)(EB/OL).(20170930).http://ivdc.chinacdc.cn/cnic/zyzx/jcfa/201709/t20170930_153976.htm.
  • Zhu AQ, Li ZJ, Zhang HJ. Spatial timing of circulating seasonal influenza a and B viruses in China from 2014 to 2018. Sci Rep. 2023 May 2;13(1):7149. doi:10.1038/s41598-023-33726-7.
  • Darvishian M, van den Heuvel ER, Bissielo A, Castilla J, Cohen C, Englund H, Gefenaite G, Huang W-T, la Bastide-van Gemert S, Martinez-Baz I, et al. Effectiveness of seasonal influenza vaccination in community-dwelling elderly people: an individual participant data meta-analysis of test-negative design case-control studies. Lancet Respir Med. 2017;5(3):200–11. doi:10.1016/S2213-2600(17)30043-7.
  • Zhu A, Liu J, Ye C, Yu J, Peng Z, Feng L, Wang L, Qin Y, Zheng Y, Li Z. Characteristics of seasonal influenza virus activity in a subtropical City in China, 2013–2019. Vaccines. 2020 Mar 1;8(1):108. doi:10.3390/vaccines8010108.
  • Sun W, Gao J, Ma Y, Li X, Gong R, Ma Y, Li T, Dong J. Epidemiological characteristics of influenza in Ningxia, 2009-2018. Chin J Dise Control. 2020;24(6):691–5+710. doi:10.16462/j.cnki.zhjbkz.2020.06.014.
  • Jia G, Zhao Q, Liu K. Analysis of influenza surveillance results in Xuchang City from 2017-2019. Mod Dis Control Prev. 2020;31(7):561–3. doi:10.13515/j.cnki.hnjpm.1006-8414.2020.07.029.
  • Liu W, He L, Ji J, Bai T, Ma Y, Wang L. Analysis of influenza surveillance results in Yan’an City, 2009-2020. J Yan’an Univ (Med Sci Ed). 2021;19(4):97–102. doi:10.19893/j.cnki.ydyxb.
  • Benjamin-Chung J, Arnold BF, Kennedy CJ, Mishra K, Pokpongkiat N, Nguyen A, Jilek W, Holbrook K, Pan E, Kirley PD, et al. Evaluation of a city-wide school-located influenza vaccination program in Oakland, California, with respect to vaccination coverage, school absences, and laboratory-confirmed influenza: A matched cohort study. PLOS Med. 2020 Aug 18;17(8):e1003238. doi:10.1371/journal.pmed.1003238.
  • Endo A, Uchida M, Hayashi N, Liu Y, Atkins KE, Kucharski AJ, Funk S. Within and between classroom transmission patterns of seasonal influenza among primary school students in Matsumoto city, Japan. Proc Natl Acad Sci USA. 2021 Nov 16;118(46):e2112605118. doi:10.1073/pnas.2112605118.
  • Krishnan A, Dar L, Saha S, Narayan VV, Kumar R, Kumar R, Amarchand R, Dhakad S, Chokker R, Choudekar A, et al. Efficacy of live attenuated and inactivated influenza vaccines among children in rural India: A 2-year, randomized, triple-blind, placebo-controlled trial. PLOS Med. 2021 Apr 29;18(4):e1003609. doi:10.1371/journal.pmed.1003609.
  • Song Q, Zhang L. Analysis of influenza sentinel surveillance results in Lanzhou from 2017 to 2021. Gansu Med J. 2022;41(9):825–8. doi:10.15975/j.cnki.gsyy.2022.09.023.
  • Bi J, Zheng L. Analysis on joinpoint regression of influenza epidemic trends in Baoan district, Shenzhencity, Guangdong province from 2011 to 2021. Preventive Med Tribune. 2023;29(7):486–9. doi:10.16406/j.pmt.issn.1672-9153.2023.7.02.
  • Lin Y, Liu H, Mao Z, Zhou Y, Wang Z, Dai M, Zhao D, Zhao Z. Analysis of epidemiological characteristics and etiological surveillance results of influenza in Kunming City From 2005 to 2021. J Preventive Med Inf. 2023;09(14):1–6. http://kns.cnki.net/kcms/detail/51.1276.R.20230809.1651.002.html.
  • Wu H, Xue M, Wu C, Ding Z, Wang X, Fu T, Yang K, Lin J, Lu Q. Estimation of influenza incidence and analysis of epidemic characteristics from 2009 to 2022 in Zhejiang Province, China. Front Public Health. 2023 May 18;11:1154944. doi:10.3389/fpubh.2023.1154944.
  • Zhang J, Wu A, Liu M, Chen Y, Liu J, Zhao Q. Epidemiological characteristics and trend analysis of influenza-like cases in Xuhui District of Shanghai from 2010 to 2019. Shanghai J Preventive Med. 2021;33(12):1136–40. doi:10.19428/j.cnki.sjpm.2021.20763.
  • Ng H, Zhang T, Wang G, Kan S, Ma G, Li Z, Chen C, Wang D, Wong M, Wong C, et al. Epidemiological characteristics of influenza A and B in Macau, 2010–2018. Virol Sin. 2021 Oct;36(5):1144–53. doi:10.1007/s12250-021-00388-6.
  • Chen C, Jiang D, Yan D, Pi L, Zhang X, Du Y, Liu X, Yang M, Zhou Y, Ding C, et al. The global region-specific epidemiologic characteristics of influenza: world health organization FluNet data from 1996 to 2021. Int J Infect Dis. 2023 Apr;129:118–24. doi:10.1016/j.ijid.2023.02.002.
  • Ye C, Zhu W, Yu J, Li Z, Zhang Y, Wang Y, Gu H, Zou W, Hao L, Hu W. Understanding the complex seasonality of seasonal influenza a and B virus transmission: Evidence from six years of surveillance data in Shanghai, China. Int J Infect Dis. 2019 Apr;81:57–65. doi:10.1016/j.ijid.2019.01.027.
  • WHO. Influenza Transmission Zones (EB/OL). (2018-9-14) (2019-3-20). https://www.who.int/influenza/surveillance_monitoring/updates/InfluenzaTransmissionZones20180914.pdf? ua=1.
  • Gao H, Pu H, Yu J, Ling P, Duan Y, Zhang T. Epidemiological and etiological characteristics of influenza in Ganzi Tibetan regions of Sichuanfrom 2009 to 2019. Chin J Pathogenic Biol. 2023;18(8):934–8. doi:10.13350/j.cjpb.230812.
  • Zhang Y, Wang X, Li Y, Ma J. Spatiotemporal analysis of influenza in China, 2005-2018. Sci Rep. 2019 Dec 23;9(1):19650. doi:10.1038/s41598-019-56104-8.
  • Wang Q, Zhang M, Qin Y, Zheng J, Zhao H, Yang X, Li ZJ, Peng ZB, Feng LZ. Analysis on seasonality, age distribution of influenza B cases and matching degree of influenza B vaccine in China, 2011-2019. Chin J Epidemiol. 2020;41(11):1813–17. doi:10.3760/cma.j.cn112338-20200318-00375.
  • Garten R, Blanton L, Elal AIA, Alabi N, Barnes J, Biggerstaff M, Brammer L, Budd AP, Burns E, Cummings CN, et al. Update: influenza activity in the United States during the 2017–18 season and composition of the 2018–19 influenza vaccine. MMWR Morb Mortal Wkly Rep. 2018 June 8;67(22):634–42. doi:10.15585/mmwr.mm6722a4.
  • Chaves SS, Naeger S, Lounaci K, Zuo Y, Loiacono MM, Pilard Q, Nealon J, Genin M, Mahe C. High-dose influenza vaccine is associated with reduced mortality among older adults with breakthrough influenza even when there is poor vaccine-strain match. Clin Infect Dis. 2023 Oct 5;77(7):1032–42. doi:10.1093/cid/ciad322.
  • Xu X, Blanton L, Elal AIA, Alabi N, Barnes J, Biggerstaff M, Brammer L, Budd AP, Burns E, Cummings CN, et al. Update: influenza activity in the United States during the 2018–19 season and composition of the 2019–20 influenza vaccine. MMWR Morb Mortal Wkly Rep. 2019 June 21;68(24):544–51. doi:10.15585/mmwr.mm6824a3.
  • Drori Y, Pando R, Sefty H, Rosenberg A, Mendelson E, Keinan-Boker L, Shohat T, Mandelboim M, Glatman-Freedman A. Influenza vaccine effectiveness against laboratory-confirmed influenza in a vaccine-mismatched influenza B-dominant season. Vaccine. 2020 Dec 14;38(52):8387–95. doi:10.1016/j.vaccine.2020.10.074.
  • Skowronski DM, Chambers C, De Serres G, Sabaiduc S, Winter AL, Dickinson JA, Gubbay JB, Drews SJ, Fonseca K, Charest H, et al. Vaccine Effectiveness Against Lineage-matched and -mismatched Influenza B Viruses Across 8 Seasons in Canada, 2010–2011 to 2017–2018. Clin Infect Dis. 2019 May 2;68(10):1754–7. doi:10.1093/cid/ciy876.
  • Sekiya T, Ohno M, Nomura N, Handabile C, Shingai M, Jackson DC, Brown LE, Kida H. Selecting and using the appropriate influenza vaccine for each individual. Viruses. 2021 May 24;13(6):971. doi:10.3390/v13060971.